News Archives - Page 3 of 4 - The Vitiligo Society

News

“What’s New in Vitiligo?” – A Free Online Webinar for Patients and Supporters

Sorry, but you do not have permission to…

26 Jan, 2026

News

When Visibility Becomes Action: Winnie Harlow & Incyte’s New Campaign for Vitiligo Awareness

Sorry, but you do not have permission to…

14 Dec, 2025

News

New Research Highlights the Emotional Impact of Vitiligo Across Cultures

Sorry, but you do not have permission to…

2 Dec, 2025

News

New Children’s Book by Winnie Harlow Due for Release in 2026

Sorry, but you do not have permission to…

20 Nov, 2025

News

Building a Stronger Future for Vitiligo Care and Advocacy

Sorry, but you do not have permission to…

28 Oct, 2025

News

Why Global Advocacy for Vitiligo Matters – and How the Vitiligo Society Represents UK Patients on the World Stage

Sorry, but you do not have permission to…

25 Sep, 2025

News

Make 2026 The Year You Do Something Incredible

Sorry, but you do not have permission to…

25 Sep, 2025

News

A Waxwork Worth Melting Over: Winnie Harlow Makes History at Madame Tussauds, New York

Sorry, but you do not have permission to…

17 Jul, 2025

News

‘More than meets the eye’ — A campaign for our community

Sorry, but you do not have permission to…

18 Jun, 2025

News

Skin Disease Now a Global Health Priority — What It Means for Vitiligo Patients

Sorry, but you do not have permission to…

11 Jun, 2025

Logo

Search articles

Latest

Post title

Popular Articles

Ruxolitinib (Opzelura) Approved for NHS Use in Treating Non‑Segmental Vitiligo

Final NICE Guidance on Ruxolitinib Published Today — A New Chapter for Vitiligo Treatment

Vitiligo Society at BAD Conference 2025: Leading the Conversation on Patient-Centred Vitiligo Care

#Letstalkvitiligo: Why Our New Campaign Makes a Difference

New Children’s Book ‘Ready For An Adventure’ Features A Character With Vitiligo

Harnessing Nanotechnology for Vitiligo: Silymarin Nanomicelles Show Promise

Ruxolitinib (Opzelura) Approved for NHS Use in Treating Non‑Segmental Vitiligo

Final NICE Guidance on Ruxolitinib Published Today — A New Chapter for Vitiligo Treatment

Vitiligo Society at BAD Conference 2025: Leading the Conversation on Patient-Centred Vitiligo Care

#Letstalkvitiligo: Why Our New Campaign Makes a Difference

New Children’s Book ‘Ready For An Adventure’ Features A Character With Vitiligo

Harnessing Nanotechnology for Vitiligo: Silymarin Nanomicelles Show Promise

Further Back

“What’s New in Vitiligo?” – A Free Online Webinar for Patients and Supporters

When Visibility Becomes Action: Winnie Harlow & Incyte’s New Campaign for Vitiligo Awareness

New Research Highlights the Emotional Impact of Vitiligo Across Cultures

New Children’s Book by Winnie Harlow Due for Release in 2026

Building a Stronger Future for Vitiligo Care and Advocacy

Why Global Advocacy for Vitiligo Matters – and How the Vitiligo Society Represents UK Patients on the World Stage

Make 2026 The Year You Do Something Incredible

A Waxwork Worth Melting Over: Winnie Harlow Makes History at Madame Tussauds, New York

‘More than meets the eye’ — A campaign for our community

Skin Disease Now a Global Health Priority — What It Means for Vitiligo Patients